Logo image of RECT.BR

RECTICEL (RECT.BR) Stock Fundamental Analysis

EBR:RECT - Euronext Brussels - BE0003656676 - Common Stock - Currency: EUR

10.68  -0.08 (-0.74%)

Fundamental Rating

5

Overall RECT gets a fundamental rating of 5 out of 10. We evaluated RECT against 18 industry peers in the Building Products industry. RECT has an average financial health and profitability rating. RECT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

RECT had positive earnings in the past year.
In the past year RECT had a positive cash flow from operations.
In the past 5 years RECT has always been profitable.
RECT had a positive operating cash flow in each of the past 5 years.
RECT.BR Yearly Net Income VS EBIT VS OCF VS FCFRECT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of RECT (3.53%) is better than 66.67% of its industry peers.
The Return On Equity of RECT (5.58%) is better than 66.67% of its industry peers.
RECT has a Return On Invested Capital of 2.85%. This is in the lower half of the industry: RECT underperforms 61.11% of its industry peers.
RECT had an Average Return On Invested Capital over the past 3 years of 2.49%. This is below the industry average of 5.60%.
The 3 year average ROIC (2.49%) for RECT is below the current ROIC(2.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.53%
ROE 5.58%
ROIC 2.85%
ROA(3y)2.99%
ROA(5y)4.61%
ROE(3y)6.36%
ROE(5y)10.34%
ROIC(3y)2.49%
ROIC(5y)2.51%
RECT.BR Yearly ROA, ROE, ROICRECT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

RECT's Profit Margin of 2.72% is fine compared to the rest of the industry. RECT outperforms 61.11% of its industry peers.
In the last couple of years the Profit Margin of RECT has declined.
The Operating Margin of RECT (2.33%) is worse than 66.67% of its industry peers.
In the last couple of years the Operating Margin of RECT has declined.
Looking at the Gross Margin, with a value of 17.46%, RECT is doing worse than 83.33% of the companies in the same industry.
RECT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.33%
PM (TTM) 2.72%
GM 17.46%
OM growth 3Y-35.7%
OM growth 5YN/A
PM growth 3Y-37.05%
PM growth 5YN/A
GM growth 3Y-3.23%
GM growth 5YN/A
RECT.BR Yearly Profit, Operating, Gross MarginsRECT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 5 10 15

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RECT is destroying value.
Compared to 1 year ago, RECT has more shares outstanding
RECT has a worse debt/assets ratio than last year.
RECT.BR Yearly Shares OutstandingRECT.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
RECT.BR Yearly Total Debt VS Total AssetsRECT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.41 indicates that RECT is not in any danger for bankruptcy at the moment.
RECT has a better Altman-Z score (3.41) than 83.33% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that RECT is not too dependend on debt financing.
The Debt to Equity ratio of RECT (0.10) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 3.41
ROIC/WACC0.37
WACC7.61%
RECT.BR Yearly LT Debt VS Equity VS FCFRECT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

RECT has a Current Ratio of 2.12. This indicates that RECT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.12, RECT belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
RECT has a Quick Ratio of 1.74. This is a normal value and indicates that RECT is financially healthy and should not expect problems in meeting its short term obligations.
RECT's Quick ratio of 1.74 is amongst the best of the industry. RECT outperforms 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.74
RECT.BR Yearly Current Assets VS Current LiabilitesRECT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 568.74% over the past year.
RECT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -30.42% yearly.
RECT shows a strong growth in Revenue. In the last year, the Revenue has grown by 71.66%.
Measured over the past years, RECT shows a quite strong growth in Revenue. The Revenue has been growing by 10.75% on average per year.
EPS 1Y (TTM)568.74%
EPS 3Y-30.42%
EPS 5YN/A
EPS Q2Q%832.94%
Revenue 1Y (TTM)71.66%
Revenue growth 3Y10.75%
Revenue growth 5YN/A
Sales Q2Q%131.74%

3.2 Future

Based on estimates for the next years, RECT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.52% on average per year.
RECT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.99% yearly.
EPS Next Y36.63%
EPS Next 2Y30.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.99%
Revenue Next 2Y7.49%
Revenue Next 3Y9.99%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
RECT.BR Yearly Revenue VS EstimatesRECT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
RECT.BR Yearly EPS VS EstimatesRECT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.84, the valuation of RECT can be described as rather expensive.
RECT's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of RECT to the average of the S&P500 Index (28.10), we can say RECT is valued inline with the index average.
A Price/Forward Earnings ratio of 22.28 indicates a rather expensive valuation of RECT.
RECT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. RECT is more expensive than 61.11% of the companies in the same industry.
RECT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.84
Fwd PE 22.28
RECT.BR Price Earnings VS Forward Price EarningsRECT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than RECT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.29
RECT.BR Per share dataRECT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RECT's earnings are expected to grow with 30.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y30.52%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

RECT has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.26, RECT pays a bit more dividend than its industry peers.
RECT's Dividend Yield is comparable with the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

On average, the dividend of RECT grows each year by 8.91%, which is quite nice.
Dividend Growth(5Y)8.91%
Div Incr Years0
Div Non Decr Years1
RECT.BR Yearly Dividends per shareRECT.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

RECT pays out 70.08% of its income as dividend. This is not a sustainable payout ratio.
The dividend of RECT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP70.08%
EPS Next 2Y30.52%
EPS Next 3YN/A
RECT.BR Yearly Income VS Free CF VS DividendRECT.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
RECT.BR Dividend Payout.RECT.BR Dividend Payout, showing the Payout Ratio.RECT.BR Dividend Payout.PayoutRetained Earnings

More info and screens

RECTICEL

EBR:RECT (5/5/2025, 7:00:00 PM)

10.68

-0.08 (-0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)04-29 2025-04-29
Earnings (Next)08-29 2025-08-29
Inst Owners25.28%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap605.02M
Analysts78.33
Price Target14.01 (31.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend0.31
Dividend Growth(5Y)8.91%
DP70.08%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 24.84
Fwd PE 22.28
P/S 0.67
P/FCF N/A
P/OCF 27.37
P/B 1.36
P/tB 2.08
EV/EBITDA 10.29
EPS(TTM)0.43
EY4.03%
EPS(NY)0.48
Fwd EY4.49%
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)0.39
OCFY3.65%
SpS16.04
BVpS7.83
TBVpS5.13
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 5.58%
ROCE 3.8%
ROIC 2.85%
ROICexc 3.75%
ROICexgc 5.87%
OM 2.33%
PM (TTM) 2.72%
GM 17.46%
FCFM N/A
ROA(3y)2.99%
ROA(5y)4.61%
ROE(3y)6.36%
ROE(5y)10.34%
ROIC(3y)2.49%
ROIC(5y)2.51%
ROICexc(3y)3.24%
ROICexc(5y)3.16%
ROICexgc(3y)4.8%
ROICexgc(5y)4.2%
ROCE(3y)3.52%
ROCE(5y)3.54%
ROICexcg growth 3Y-8.14%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.74%
ROICexc growth 5YN/A
OM growth 3Y-35.7%
OM growth 5YN/A
PM growth 3Y-37.05%
PM growth 5YN/A
GM growth 3Y-3.23%
GM growth 5YN/A
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 0.89
Cap/Depr 111.08%
Cap/Sales 3.75%
Interest Coverage 13.2
Cash Conversion 42.62%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.74
Altman-Z 3.41
F-Score5
WACC7.61%
ROIC/WACC0.37
Cap/Depr(3y)90.07%
Cap/Depr(5y)73.74%
Cap/Sales(3y)3.97%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)568.74%
EPS 3Y-30.42%
EPS 5YN/A
EPS Q2Q%832.94%
EPS Next Y36.63%
EPS Next 2Y30.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)71.66%
Revenue growth 3Y10.75%
Revenue growth 5YN/A
Sales Q2Q%131.74%
Revenue Next Year7.99%
Revenue Next 2Y7.49%
Revenue Next 3Y9.99%
Revenue Next 5YN/A
EBIT growth 1Y33.02%
EBIT growth 3Y-28.79%
EBIT growth 5YN/A
EBIT Next Year182.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-146.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.87%
OCF growth 3Y-41.91%
OCF growth 5YN/A